Oleanolic acid nanosuspensions: Preparation, in-vitro characterization and enhanced hepatoprotective effect

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 2, 2005, Pages 259-264

  Chen, Yajun ^a   Liu, Jie ^a   Yang, Xiangliang ^a   Zhao, Xiaoling ^a   Xu, Huibi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBON TETRACHLORIDE; NANOPARTICLE; OLEANOLIC ACID; TRITERPENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOAVAILABILITY; CHINA; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; HEPATITIS; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRECIPITATION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBON TETRACHLORIDE; CHEMISTRY, PHARMACEUTICAL; CHINA; DOSAGE FORMS; DRUG EVALUATION, PRECLINICAL; HEPATOCYTES; INJECTIONS, SUBCUTANEOUS; LIVER DISEASES; MALONDIALDEHYDE; MEDICINE, CHINESE TRADITIONAL; MICE; NANOSTRUCTURES; OLEANOLIC ACID; PARTICLE SIZE; SOLUBILITY; SUSPENSIONS; TRITERPENES; X-RAY DIFFRACTION;

EID: 12344326615     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055407     Document Type: Article

References (28)

1. Chen, X. X., Vaughn, J. M., Yacaman, M. J., Williams, R. O., Johnston, K. P. (2004) Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution. J. Pharm. Sci. 93:
2. Dubes, A., Lopez, H. P., Abdelwahed, W., Degobert, G., Fessi, H. (2003) Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur. J. Pharm. Biopharm. 55: 279-282
3. Fessi, H., Devissaguet, J. P., Puisieux, F., Thies, C. (1992) Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent No. 5118528
4. Guo, M. Q., Zhang, S. Q., Song, F. R., Wang, D. W., Liu, Z. Q., Liu, S. Y. (2003) Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 38: 723-731
5. Hunan Medical Institute (1975) Pharmacological studies of hepatoprotective compounds from Swertia mileensis. Zhong Cao Yao 6: 47-62
6. Hye, G. J. (1999) Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol. Lett. 105: 215-222
7. Kayser, O. (2000) Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages. Int. J. Pharm. 196: 253-256
8. Liu, J. (1995) Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49: 57-68
9. Liversidge, E. M., Liversidge, G. G., Cooper, E. R. (2003) Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18: 113-120
10. Liversidge, G. G., Cundy, K. C. (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125: 91-97
11. Liversidge, G. G., Cundy, K. C., Bisshop, J., Czekai, D. (1991) Surface modified drug nanoparticles. US Patent No. 5145684
12. Montasser, I., Fessi, H., Coleman, A. W. (2003) Atomic force microscopy imaging of novel type polymeric colloidal nanostructures. Eur. J. Pharm. Biopharm. 54: 281-284
13. Mosharra, M., Nyström, C. (1995) The effect of particle size and shape on the surface specific dissolution rate of micronized practically insoluble drugs. Int. J. Pharm. 122: 35-47
14. Müller, R. H., Peters, K. (1998) Nanosuspensions for the formulation of poorly soluble drugs: preparation by a size-reduced technique. Int. J. Pharm. 160: 229-237
15. Müller, R. H., Becker, R., Peters, K. K. (1998) Pharmaceutical nanosuspensions for medicament administration as system of increased saturation solubility and rate of solution. US Patent No. 5858410
16. Müller, R. H., Jacobs, C., Kayser, O. (2001) Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47: 3-19
17. Patravale, V. B., Date, A. A., Kulkarni, R. M. (2004) Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 56: 827-840
18. Ponchel, G., Irache, J. M. (1998) Specific and non-specific bioadhesive paniculate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34: 191-219
19. Rasenack, N., Steckel, H., Müller, B. W. (2003) Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. J. Pharm. Sci. 92: 35-44
20. Raucy, J. L., Kraner, J. C., Lasker, H. M. (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23: 1-20
21. Reverchon, E., Della Porta, G., Spada, A. (2003) Ampicillin micronization by supercritical assisted atomization. J. Pharm. Pharmacol. 55: 1465-1471
22. 2 and cryogenic spray-freezing technologies. Drug Dev. Ind. Pharm. 27: 1003-1015
23. Ruanshi, Y. Q., Zhao, H. R. (2003) Preparation of oleanolic acid solid dispersion systems and their dissolution in vitro. J. China Pharm. Univ. 34: 236-239
24. Wang, B., Jiang, C. H. (1992) Studies on oleanolic acid. Chin. Pharm. J. 7: 393-397
25. Xia, K. Y., Yan, R. N., Fang, H. R. (1988) In vitro dissolution of oleanolic acid formulations. Zhong Cao Yao 19: 11-15
26. Xiang, D. X., Tao, M. W., Wang, F., Li, H. D. (2002) Studies on formation and solubilizing mechanism of oleanolic acid solid dispersions. Zhong Cao Yao 33: 311-314
27. Yan, Y. D., Feng, B., Huang, X. J., Zhou, Z.G. (1995) Studies on the oleanolic acid-β-cyclodextrin inclusion. Chin. Tradit. Patent Med. 17: 2-4
28. Yim, T. K., Wu, W. K., Pak, W. F., Ko, K. M. (2001) Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother. Res. 15: 589-592